Immunogen reported $348.94M in Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Agios Pharmaceuticals AGIO:US USD 1.24B 58.4M
Amgen AMGN:US USD 65.12B 1.42B
Astellas Pharma 4503:JP JPY 2.51T 69.71B
AstraZeneca AZN:LN USD 96.48B 2.3B
Bluebird Bio BLUE:US USD 520.1M 53.49M
Emergent Biosolutions EBS:US USD 3.17B 258.1M
Exelixis EXEL:US USD 3.07B 110.12M
Halozyme Therapeutics HALO:US USD 1.84B 23.03M
Heron Therapeutics HRTX:US USD 271.95M 27.99M
Immunogen IMGN:US USD 348.94M 9.86M
Intrexon XON:US USD 215.98M 43.27M
Karyopharm Therapeutics KPTI:US USD 358.17M 126.94M
Macrogenics MGNX:US USD 280.47M 85.12M
Nektar Therapeutics NKTR:US USD 710.6M 70.41M
Novartis NVS:US USD 117.45B 1.01B
Regeneron Pharmaceuticals REGN:US USD 29.21B 1.54B
Roche Holding ROG:VX 88.15B 1.42B
Seattle Genetics SGEN:US USD 3.67B 55.45M